Tilray Medical

Tilray Medical, a division of Tilray Brands, Inc. (NASDAQ:TLRY) (TSX:TLRY) announced on Wednesday the launch of Redecan EU-GMP certified medical cannabis products in Australia. What Happened: The following Redecan products are now available for medical cannabis patients in Australia...

Tilray Medical, a division of Canadian cannabis giant Tilray Brands, Inc. (NASDAQ:TLRY) (TSX:TLRY) announced on Monday a new scientific publication supported by Tilray Medical titled, Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms: A Case Series (TOMAS). The study,...

A new study conducted by a division of Tilray Brands, Inc. (NASDAQ:TLRY) reveals that a substantial majority of medical marijuana patients over the age of 50 are utilizing cannabis to manage chronic pain and arthritis. This research highlights the growing trend among older adults turning to...

Tilray Medical, a division of Tilray Brands, Inc. (NASDAQ:TLRY) (TSX:TLRY) released its new scientific publication on Tuesday titled, “Medical Cannabis for Patients Over Age 50: A Multi-Site, Prospective Study of Patterns of Use and Health Outcomes.“ The new research builds on a...

Older patients comprise a growing subset of medical marijuana patients, according to a new study. Titled “Age-related Patterns of Medical Cannabis Use: A Survey of Authorized Patients in Canada,” the new scientific publication presents the consumption trends observed in patients and the...

The European cannabis market is one of the most rapidly expanding markets globally. Prohibition Partners revealed in its latest report on cannabis in Europe that the combined market size of all CBD categories surpassed €2 billion ($2.2 billion) in 2023. The report called Germany, Czech Republic,...

MMJ.com which helps patients access medical marijuana through a telehealth platform, announced on Friday that it is expanding its services to 26 states. The move is expected to facilitate online consultations with state-certified doctors for medical cannabis patients. Other implications for...

On Monday, Tilray Medical, a division of Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY), announced its contribution to an independent clinical trial to research the efficacy of medical cannabis as a treatment for glioblastoma, which is a severe form of brain cancer. The clinical...

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) announced that its medical cannabis division, Tilray Medical and FL Group, the company’s subsidiary in Italy, have received authorization from Italy’s Ministry of Health to distribute three new medical cannabis compounds. These medical...

Tilray Medical, a medical cannabis division of Tilray Brands, Inc.,(NASDAQ: TLRY) (TSX:TLRY) has launched Take Back Control, a new platform developed to connect women with free resources on medical cannabis and to help destigmatize the use of medical cannabis in women’s healthcare practices....

Although the CDC estimates that 48.2 million Americans (18 percent of the population) used cannabis in 2019, at least eight states have passed laws prohibiting the denial of a transplant solely on the basis of marijuana use. Due to the lack of consensus among medical experts about cannabis use and...

Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY), announced that FL Group S.R.L., a division of Tilray Medical in Italy, has received approval from the Italian Ministry of Health to import and distribute Tilray’s medical cannabis oral solution THC25 across the country. Denise Faltischek, Tilray...

Tilray Brands, Inc.’s (Nasdaq: TLRY) (TSX:TLRY) Tilray Medical, has released new medical cannabis products, under Tilray and Aphria brands and launched CannaPoints, a new program designed to support patients through their medical cannabis journey. Blair MacNeil, president, Tilray Canada,...

Tilray Brands, Inc.’s (NASDAQ: TLRY) (TSX:TLRY) medical cannabis division, Tilray Medical, launched a new cannabis education platform, WeCare-MedicalCannabis, dedicated to providing resources and educating healthcare practitioners and patients about medical cannabis. WeCare-MedicalCannabis...

Tilray Brands, Inc.’s (NASDAQ: TLRY) (TSX:TLRY) medical cannabis division, Tilray Medical, has expanded its medical cannabis offerings in the United Kingdom. Denise Faltischek, Tilray’s chief strategy officer, and head of international business, stated, “The demand for medical...